SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-234071
Filing Date
2021-08-03
Accepted
2021-08-03 08:10:58
Documents
15
Period of Report
2021-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d167868d8k.htm   iXBRL 8-K 31453
2 EX-10.1 d167868dex101.htm EX-10.1 66652
3 EX-99.1 d167868dex991.htm EX-99.1 196333
7 GRAPHIC g167868g0803004540493.jpg GRAPHIC 3274
  Complete submission text file 0001193125-21-234071.txt   472669

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alny-20210802.xsd EX-101.SCH 2887
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20210802_lab.xml EX-101.LAB 18137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20210802_pre.xml EX-101.PRE 11404
8 EXTRACTED XBRL INSTANCE DOCUMENT d167868d8k_htm.xml XML 3382
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 211138066
SIC: 2834 Pharmaceutical Preparations